bioMerieux (OTCMKTS:BMXMF) Sees Unusually-High Trading Volume – Time to Buy?

bioMerieux (OTCMKTS:BMXMF) saw unusually-high trading volume on Friday . Approximately 137 shares were traded during mid-day trading, an increase of 37% from the previous session’s volume of 100 shares.The stock last traded at $110.00 and had previously closed at $112.57.

Analyst Upgrades and Downgrades

Separately, BNP Paribas Exane cut shares of bioMerieux to a “neutral” rating in a report on Wednesday, January 28th. Two investment analysts have rated the stock with a Hold rating, According to MarketBeat, bioMerieux currently has a consensus rating of “Hold”.

bioMerieux Price Performance

The firm’s fifty day moving average price is $121.78 and its two-hundred day moving average price is $129.03. The company has a current ratio of 2.27, a quick ratio of 1.30 and a debt-to-equity ratio of 0.08.

bioMerieux Company Profile

bioMérieux is a global leader in in vitro diagnostics, specializing in the development, manufacture and distribution of diagnostic solutions that determine the source of disease and contamination to improve patient health and ensure consumer safety. The company’s product portfolio encompasses a broad range of assays and instruments for microbiological and immunoassay testing, including molecular diagnostics for infectious diseases, immunoassays for autoimmune and oncology markers, and traditional microbial identification and antimicrobial susceptibility testing.